Long Reads: Big Pharma's Toxic Record w/ Nick Dearden

Long Reads: Big Pharma's Toxic Record w/ Nick...

Suivant

The Dig: Economic Warfare w/ Aslı Bâli, Esfandyar Batmanghelidj, Nicholas Mulder

Featuring Aslı Bâli, Esfandyar Batmanghelidj, and Nicholas Mulder on the economic warfare unfolding with the US-Israeli war on Iran — and beyond. Support The Dig at Patreon.com/TheDig Find Ethnic Studies at the Crossroads at UCPress.edu Buy Cold War on Five Continents at Haymarke ...  Afficher plus

Long Reads: El Salvador’s Jailer in Chief

Donald Trump is a huge fan of Nayib Bukele, the current president of El Salvador. Last April, Bukele visited the White House and offered to help with a campaign of domestic repression in the United States. In El Salvador, which relies on US support, Bukele’s government has detain ...  Afficher plus

Épisodes Recommandés

Downstream: Big Pharma’s Secrets w/ Nick Dearden
Novara Media

Nick Dearden has been an economic justice campaigner for over 20 years, and his attention was on the pharmaceutical industry when Covid-19 hit. But as the world began to sing the praises of pharmaceutical companies, Nick saw an unprecedented PR coup. Giant corporations capitalise ...  Afficher plus

Why One Drug Company Held Back a Better Drug
The Daily

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

  Afficher plus

Sawbones: Patents vs. Life-Saving Drugs
Sawbones: A Marital Tour of Misguided Medicine

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

  Afficher plus

Sick Money (Pt 2): How Big Pharma made a killing from the pandemic
The Story

The second of two episodes this week, taking a deep dive into the pharmaceutical industry.

Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vacci ...

  Afficher plus